Oxford–AstraZeneca COVID-19 vaccine

The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1.

Source: Wikipedia — Oxford–AstraZeneca COVID-19 vaccine (CC BY-SA 4.0)